JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases

Conditions: Autoimmune Diseases Interventions: Genetic: JY231 Sponsors: Shanxi Bethune Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials